MCFARLANE NEIL F. (Chief Executive Officer) received a stock award from ADAMAS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/24/2021ACC: 0001328143-21-000093
Officer· Chief Executive Officer
Since Sep 2019
-975K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
75K acquired · 1.05M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
14.3%
11/24/2021
525K→600K
Common Stock
Direct
Shares
−600K
Price / share
—
Trade value
—
% of position
New position
11/24/2021
600K→0.00
Total
Net shares
−525K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2021 | A · Award | +75K | — | — | 14.3% | 525K | 600K |
| Common Stock Direct | 11/24/2021 | U · U | −600K | — | — | New position | 600K | 0.00 |
| Total | −525K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
−250K
Strike price
6.25
Held after
0.00
Exercisable
—
11/24/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
200K shares
Shares
−200K
Strike price
1.99
Held after
0.00
Exercisable
—
11/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock250K shares | 11/24/2021 | D · Disposition | −250K | 6.25 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock200K shares | 11/24/2021 | D · Disposition | −200K | 1.99 | — | 0.00 |